Thai
Thai
Thai
Thai
Thai
Thai
Carrier Screening is a genetic test for prospective parents to identify hidden genetic abnormalities and assess the risk of transmitting hereditary diseases to their children. This screening is highly recommended for all couples, even those without a family history of genetic disorders, as carriers often do not exhibit any symptoms. Understanding these risks in advance allows for safe pregnancy planning (such as utilizing ICSI combined with PGT embryo screening or prenatal diagnosis), thereby minimizing the chances of severe genetic conditions in the child and providing greater confidence in starting a family.
Having a child is a joyous occasion for many couples, but not everyone can be certain that their baby will be born perfectly healthy. This is especially true when parents may unknowingly be a single gene disorder carrier. The risk of passing on genetic diseases is a significant concern for many. Carrier Screening was developed to provide peace of mind before pregnancy and to ensure a safer family planning process.
Blood samples are collected from both parents to analyze genes associated with genetic disorders.
The laboratory analyzes the genetic material using Next-Generation Sequencing (NGS) technology, which can simultaneously screen hundreds of abnormal genes.
A thorough examination and analysis are conducted to determine if either or both parents are carriers of the genetic disorder.
If both partners are found to be carriers, the doctor will assess the inheritance pattern and calculate the probability of the child inheriting the abnormal genes.
The doctor will provide guidance on the most appropriate medical approach, such as ICSI + PGT-M, to select disease-free embryos prior to transferring them back into the uterine cavity.
Carrier Screening does not focus solely on the genetic risk of either the female or male partner. Instead, both partners are assessed together to determine whether they carry genetic variants associated with the same inherited genetic disorder.
If one partner is identified as a carrier, the physician may recommend testing the other partner to further assess the potential risk of passing the condition on to their child.
If Carrier Screening identifies a potential genetic risk, having this information before pregnancy provides couples with more options for reproductive planning. These may range from natural conception followed by appropriate prenatal diagnostic testing to IVF/ICSI combined with PGT-M. When a specific single-gene disorder has been identified and is suitable for embryo testing.The most appropriate approach depends on the specific genetic variant identified, the associated condition, and the individual risk profile of each family.
Understanding your genetic status before attempting pregnancy gives couples more time to discuss and carefully consider their reproductive options. The results can be reviewed with a physician or genetic counselor to assess the potential risk and determine an appropriate reproductive plan for the family from the outset.
Carrier Screening can help couples determine whether they carry genetic variants associated with the specific conditions included in the test, even when they have no symptoms or signs of disease.If one partner is found to be a carrier, the physician can assess the potential risk and determine whether testing of the other partner is appropriate. If both partners are found to be carriers of variants associated with the same inherited disorder, the couple can discuss appropriate reproductive options before pregnancy.Depending on the specific condition and individual circumstances, options may include embryo genetic testing in conjunction with IVF/ICSI, such as PGT-M, or prenatal diagnostic testing during pregnancy.
Carrier Screening is a genetic test to determine if an individual is a “carrier” of an abnormal gene that could be passed on to their child, even if the carrier does not exhibit any symptoms of the disease. This test helps couples planning to have children understand their risks, as well as the possibility of a safe pregnancy through assisted reproductive technologies, such as IVF/ICSI combined with Preimplantation Genetic Testing (PGT), to reduce the risk of genetic diseases that could affect their future child’s quality of life.
Generally, a standard health check-up only covers basic blood tests, infectious diseases, and screening for a few types of thalassemia carriers. In contrast, innovative gene decoding technologies like Next-Generation Sequencing (NGS) can screen hundreds of genes simultaneously in a single test. This technological advancement makes Carrier Screening more efficient, providing clearer, more comprehensive, and more accurate information than before. It is considered an important tool that effectively helps reduce the risk of potential health problems for the baby.
Although pregnancy is a joyous time, unseen genetic risks can become a concern later on. However, Carrier Screening is a crucial preventive measure, as it can help increase couples’ confidence in several ways:
These genetic diseases are just a few of the most common ones, all serving as examples that reflect how in-depth carrier screening is a medical option that can truly help reduce risks and increase the chances of a child being born healthy.
Carrier Screening is considered to be an important step for couples who want to plan their family carefully, as it helps reduce the risk of transmitting genetic diseases and increases confidence in having children.
All couples planning to have children can undergo testing, even if they do not have a family history of genetic disorders, as carriers may not exhibit any symptoms. It is particularly recommended for couples with a history of recurrent miscarriages, those with family members suffering from genetic diseases, or individuals entering the IVF/ICSI process, to carefully assess the risks.
Currently, Next-Generation Sequencing (NGS) technology is utilized, which can detect mutations in hundreds of genes simultaneously. It offers high accuracy and provides more in-depth information than general health check-ups. However, the accuracy also depends on the laboratory and the interpretation by the attending medical team.
There is a clear difference. A general pre-pregnancy health check-up typically involves blood tests to identify abnormalities such as infectious diseases or assess organ function. In contrast, Carrier Screening focuses on genetic analysis to determine the likelihood of transmitting genetic diseases to the child. It provides a deeper level of insight and helps in planning a safe pregnancy.
Couples still have the opportunity to have a healthy child. They can opt for assisted reproductive technology (ICSI) combined with Preimplantation Genetic Testing (PGT) to select embryos without the abnormal gene. Alternatively, they may choose other methods, such as Prenatal Diagnosis, as recommended by a specialist, to ensure the highest level of safety during pregnancy.